- Home
- AXIA vs STE Comparison
AXIA vs STE Comparison
Compare AXIA & STE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AXIA | STE |
|---|---|---|
| Founded | 1962 | 1985 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Industrial Specialties |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.7B | 25.9B |
| IPO Year | N/A | 1992 |
Fundamental Metrics
Financial Performance| Metric | AXIA | STE |
|---|---|---|
| Price | $8.97 | $256.65 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $268.25 |
| AVG Volume (30 Days) | ★ 2.7M | 594.7K |
| Earning Date | 02-26-2026 | 02-04-2026 |
| Dividend Yield | ★ 7.12% | 0.98% |
| EPS Growth | N/A | ★ 59.39 |
| EPS | N/A | ★ 6.97 |
| Revenue | ★ $8,001,033,499.00 | $5,702,415,000.00 |
| Revenue This Year | $0.09 | $9.61 |
| Revenue Next Year | $13.42 | $6.23 |
| P/E Ratio | ★ N/A | $36.75 |
| Revenue Growth | ★ 11.98 | 7.08 |
| 52 Week Low | $4.32 | $200.98 |
| 52 Week High | $10.03 | $268.60 |
Technical Indicators
Market Signals| Indicator | AXIA | STE |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 51.12 |
| Support Level | N/A | $253.87 |
| Resistance Level | N/A | $257.56 |
| Average True Range (ATR) | 0.00 | 4.49 |
| MACD | 0.00 | -0.26 |
| Stochastic Oscillator | 0.00 | 44.08 |
Price Performance
Historical ComparisonAbout AXIA AXIA Energia American
Axia Energia is engaged in the generation, transmission, and commercialization of electricity in Brazil. The company operates a portfolio of wind, thermal, hydro, and nuclear power plants located throughout the country.
About STE STERIS plc (Ireland)
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.